111 related articles for article (PubMed ID: 29080681)
21. Pancreatic β-cell failure mediated by mTORC1 hyperactivity and autophagic impairment.
Bartolomé A; Kimura-Koyanagi M; Asahara S; Guillén C; Inoue H; Teruyama K; Shimizu S; Kanno A; García-Aguilar A; Koike M; Uchiyama Y; Benito M; Noda T; Kido Y
Diabetes; 2014 Sep; 63(9):2996-3008. PubMed ID: 24740570
[TBL] [Abstract][Full Text] [Related]
22. Constitutive adipocyte mTORC1 activation enhances mitochondrial activity and reduces visceral adiposity in mice.
Magdalon J; Chimin P; Belchior T; Neves RX; Vieira-Lara MA; Andrade ML; Farias TS; Bolsoni-Lopes A; Paschoal VA; Yamashita AS; Kowaltowski AJ; Festuccia WT
Biochim Biophys Acta; 2016 May; 1861(5):430-8. PubMed ID: 26923434
[TBL] [Abstract][Full Text] [Related]
23. mTORC1 activity negatively regulates human hair follicle growth and pigmentation.
Suzuki T; Chéret J; Scala FD; Akhundlu A; Gherardini J; Demetrius DL; O'Sullivan JDB; Kuka Epstein G; Bauman AJ; Demetriades C; Paus R
EMBO Rep; 2023 Jul; 24(7):e56574. PubMed ID: 37212043
[TBL] [Abstract][Full Text] [Related]
24. Bridges between mitochondrial oxidative stress, ER stress and mTOR signaling in pancreatic β cells.
Wang J; Yang X; Zhang J
Cell Signal; 2016 Aug; 28(8):1099-104. PubMed ID: 27185188
[TBL] [Abstract][Full Text] [Related]
25. mTORC1 Prevents Preosteoblast Differentiation through the Notch Signaling Pathway.
Huang B; Wang Y; Wang W; Chen J; Lai P; Liu Z; Yan B; Xu S; Zhang Z; Zeng C; Rong L; Liu B; Cai D; Jin D; Bai X
PLoS Genet; 2015 Aug; 11(8):e1005426. PubMed ID: 26241748
[TBL] [Abstract][Full Text] [Related]
26. Inhibitory effect of the water-soluble polymer-wrapped derivative of fullerene on UVA-induced melanogenesis via downregulation of tyrosinase expression in human melanocytes and skin tissues.
Xiao L; Matsubayashi K; Miwa N
Arch Dermatol Res; 2007 Aug; 299(5-6):245-57. PubMed ID: 17333222
[TBL] [Abstract][Full Text] [Related]
27. Selective Tuberous Sclerosis Complex 1 Gene Deletion in Smooth Muscle Activates Mammalian Target of Rapamycin Signaling and Induces Pulmonary Hypertension.
Houssaini A; Abid S; Derumeaux G; Wan F; Parpaleix A; Rideau D; Marcos E; Kebe K; Czibik G; Sawaki D; Treins C; Dubois-Randé JL; Li Z; Amsellem V; Lipskaia L; Pende M; Adnot S
Am J Respir Cell Mol Biol; 2016 Sep; 55(3):352-67. PubMed ID: 26991739
[TBL] [Abstract][Full Text] [Related]
28. Efficacy of combined inhibition of mTOR and ERK/MAPK pathways in treating a tuberous sclerosis complex cell model.
Mi R; Ma J; Zhang D; Li L; Zhang H
J Genet Genomics; 2009 Jun; 36(6):355-61. PubMed ID: 19539245
[TBL] [Abstract][Full Text] [Related]
29. Pyridinyl imidazole compounds interfere with melanosomes sorting through the inhibition of cyclin G-associated Kinase, a regulator of cathepsins maturation.
Bellei B; Pitisci A; Migliano E; Cardinali G; Picardo M
Cell Signal; 2014 Apr; 26(4):716-23. PubMed ID: 24412755
[TBL] [Abstract][Full Text] [Related]
30. Effects of combining rapamycin and resveratrol on apoptosis and growth of TSC2-deficient xenograft tumors.
Alayev A; Salamon RS; Sun Y; Schwartz NS; Li C; Yu JJ; Holz MK
Am J Respir Cell Mol Biol; 2015 Nov; 53(5):637-46. PubMed ID: 25844891
[TBL] [Abstract][Full Text] [Related]
31. The Ap3b1 gene regulates the ocular melanosome biogenesis and tyrosinase distribution differently from the Hps1 gene.
Jing R; Dong X; Li K; Yan J; Chen X; Feng L
Exp Eye Res; 2014 Nov; 128():57-66. PubMed ID: 25160823
[TBL] [Abstract][Full Text] [Related]
32. Efficacy of Dual Inhibition of Glycolysis and Glutaminolysis for Therapy of Renal Lesions in Tsc2
Jones AT; Narov K; Yang J; Sampson JR; Shen MH
Neoplasia; 2019 Feb; 21(2):230-238. PubMed ID: 30622053
[TBL] [Abstract][Full Text] [Related]
33. Hypopigmenting agents: an updated review on biological, chemical and clinical aspects.
Solano F; Briganti S; Picardo M; Ghanem G
Pigment Cell Res; 2006 Dec; 19(6):550-71. PubMed ID: 17083484
[TBL] [Abstract][Full Text] [Related]
34. Precise role of dermal fibroblasts on melanocyte pigmentation.
Wang Y; Viennet C; Robin S; Berthon JY; He L; Humbert P
J Dermatol Sci; 2017 Nov; 88(2):159-166. PubMed ID: 28711237
[TBL] [Abstract][Full Text] [Related]
35. β-Cryptoxanthin suppresses UVB-induced melanogenesis in mouse: involvement of the inhibition of prostaglandin E2 and melanocyte-stimulating hormone pathways.
Shimoda H; Shan SJ; Tanaka J; Maoka T
J Pharm Pharmacol; 2012 Aug; 64(8):1165-76. PubMed ID: 22775220
[TBL] [Abstract][Full Text] [Related]
36. Targeting protein homeostasis with nelfinavir/salinomycin dual therapy effectively induces death of mTORC1 hyperactive cells.
Dunlop EA; Johnson CE; Wiltshire M; Errington RJ; Tee AR
Oncotarget; 2017 Jul; 8(30):48711-48724. PubMed ID: 28415776
[TBL] [Abstract][Full Text] [Related]
37. Tsc1 deficiency-mediated mTOR hyperactivation in vascular endothelial cells causes angiogenesis defects and embryonic lethality.
Ma A; Wang L; Gao Y; Chang Z; Peng H; Zeng N; Gui YS; Tian X; Li X; Cai B; Zhang H; Xu KF
Hum Mol Genet; 2014 Feb; 23(3):693-705. PubMed ID: 24129405
[TBL] [Abstract][Full Text] [Related]
38. Sustained activation of mTORC1 in macrophages increases AMPKα-dependent autophagy to maintain cellular homeostasis.
Pan H; Zhong XP; Lee S
BMC Biochem; 2016 Jul; 17(1):14. PubMed ID: 27387347
[TBL] [Abstract][Full Text] [Related]
39. MITF-M regulates melanogenesis in mouse melanocytes.
Chen T; Zhao B; Liu Y; Wang R; Yang Y; Yang L; Dong C
J Dermatol Sci; 2018 Jun; 90(3):253-262. PubMed ID: 29496358
[TBL] [Abstract][Full Text] [Related]
40. Tranexamic acid inhibits melanogenesis by activating the autophagy system in cultured melanoma cells.
Cho YH; Park JE; Lim DS; Lee JS
J Dermatol Sci; 2017 Oct; 88(1):96-102. PubMed ID: 28669590
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
